Work

What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment

Year: 2015
Type: review
Abstract: // Enrico Bronte 1,* , Giuseppe Bronte 1,* , Giuseppina Novo 2,* , Fabrizio Bronte 3 , Maria Grazia Bavetta 3 , Giuseppe Lo Re 4 , Giuseppe Brancatelli 4 , Viviana Bazan 1 , Clara Natoli 5 , Salvatore Novo 2 and Antonio Russo 1 1 Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy 2 Department of Internal Medicine and Cardiovascular Disease, University of Palermo, Palermo, Italy 3 DiBiMIS, Section of Gastroenterology, University of Palermo, Palermo, Italy 4 Department of Radiology, University of Palermo, Palermo, Italy 5 Department of Medical, Oral and Biotechnological Sciences, University “G. D’Annunzio”, Chieti, Italy * These authors contributed equally to this work Correspondence to: Antonio Russo, email: // Keywords : B-RAF, B-RAF inhibitors, cardio-oncology, cardiotoxicity, dabrafenib Received : August 04, 2015 Accepted : August 22, 2015 Published : September 28, 2015 Abstract The RAS-related signalling cascade has a fundamental role in cell. It activates differentiation and survival. It is particularly important one of its molecules, B-RAF. B-RAF has been a central point for research, especially in melanoma. Indeed, it lacked effective therapeutic weapons since the early years of its study. Molecules targeting B-RAF have been developed. Nowadays, two classes of molecules are approved by FDA. Multi-target molecules, such as Sorafenib and Regorafenib, and selective molecules, such as Vemurafenib and Dabrafenib. Many other molecules are still under investigation. Most of them are studied in phase 1 trials. Clinical studies correlate B-RAF inhibitors and QT prolongation. Though this cardiovascular side effect is not common using these drugs, it must be noticed early and recognize its signals. Indeed, Oncologists and Cardiologists should work in cooperation to prevent lethal events, such as fatal arrhythmias or sudden cardiac death. These events could originate from an uncontrolled QT prolongation.
Source: Oncotarget
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2228476560
FWCI: 1.133
Cites: 97
Cited by: 66
Related to: 10